EmilyAnnDiMangoMD

Critical Care Medicine, Pleural Disease

Associate Professor, Medicine, Columbia University College of Phys & Surg

Overview of Dr. DiMango

Dr. Emily DiMango is a pulmonologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from New York University Grossman School of Medicine and has been in practice 28 years. Dr. DiMango accepts several types of health insurance, listed below. She is one of 238 doctors at New York-Presbyterian Hospital and one of 97 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Pulmonology. She has more than 70 publications and over 500 citings.

Office
622 W 168th St
New York, NY 10032
Book by Phone+1(929) 334-3675

Education & Training

New York Presbyterian Hospital (Columbia Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1994
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1989 - 1992
New York University School of MedicineClass of 1989

Certifications & Licensure

NY State Medical License 1991 - 2026

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2014
New York Magazine: Top Doctors Castle Connolly, 2013
Super Doctor SuperDoctors.com

Clinical Trials

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma Start of enrollment: 2005 Sep 01
Completed
Phase 2, Phase 3
Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA) Start of enrollment: 2006 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) Start of enrollment: 2007 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) Start of enrollment: 2008 May 01
Completed
Phase 3
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) Start of enrollment: 2010 Nov 01
Completed
Phase 2
Environmental Intervention Versus Standard Care to Reduce Pharmacologic Therapy for Asthma Start of enrollment: 2011 Apr 01
Completed
Not Applicable
Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
Completed
Phase 2
Ginger's Therapeutic Potential in Asthma Start of enrollment: 2019 Aug 22
Completed
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

131 citations
KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma
Katherine N. Cahill, Howard R. Katz, Jing Cui, Juying Lai, Shamsah Kazani
The New England Journal of Medicine. 2017-05-17
67 citations
Impact of Race on Asthma Treatment Failures in the Asthma Clinical Research Network
Michael E. Wechsler, Mario Castro, Erik Lehman, Vernon M. Chinchilli, E. Rand Sutherland
American Journal of Respiratory and Critical Care Medicine. 2011-12-01
345 citations
Tiotropium bromide step-up therapy for adults with uncontrolled asthma
Stephen P. Peters, Susan J. Kunselman, Nikolina Icitovic, Wendy C. Moore, Rodolfo M. Pascual
The New England Journal of Medicine. 2010-10-28

Journal Articles

Abnormal Microarchitecture and Stiffness in Postmenopausal Women Using Chronic Inhaled Glucocorticoids
E Dimango, E Shane, E M Stein, Osteoporosis international

Press Mentions

Man Credits Active Lifestyle, Discipline to Battling Cystic FibrosisJune 15th, 2016

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment